Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MedVentive
company
About
MedVentive, an accountable care organization, offers MedVentive Population Manager, a network platform for clinical integration programs.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $12M
- Industries
- Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Active
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients.Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$12M
MedVentive has raised a total of
$12M
in funding over 2 rounds. Their latest funding was raised on
Oct 21, 2011 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 21, 2011 | Series D | $12M | 1 |
National Healthcare Services
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
MedVentive is funded by 1 investors.
National Healthcare Services
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Healthcare Services
|
Yes | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
